Dunlop A. Sinclair - Insider Transactions
Insider Type
individual
Companies
1
Average
893,756
Total Txns
11
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2023 | 0 | 4 | -4 | 0.00 | 4,555,099.95 | -4,555,099.95 |
| 2024 | 0 | 5 | -5 | 0.00 | 3,860,592.65 | -3,860,592.65 |
| 2025 | 0 | 2 | -2 | 0.00 | 1,415,618.76 | -1,415,618.76 |
| Total: | 0 | 11 | 10 | 0.00 | 9,831,311.36 | -9,831,311.36 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. Common Stock IE00BKTWZ451 |
22.58 USD |
31,092 Sold |
702,057 USD |
30/09/2025 | 30/09/2025 |
| Apellis Pharmaceuticals, Inc. Common Stock IE00BKTWZ451 |
22.95 USD |
31,092 Sold |
713,561 USD |
19/09/2025 | 19/09/2025 |
| Apellis Pharmaceuticals, Inc. Common Stock IE00BKTWZ451 |
36.79 USD |
7,524 Sold |
276,808 USD |
16/09/2024 | 16/09/2024 |
| Apellis Pharmaceuticals, Inc. Common Stock IE00BKTWZ451 |
36.09 USD |
29,476 Sold |
1,063,789 USD |
16/09/2024 | 16/09/2024 |
| Apellis Pharmaceuticals, Inc. Common Stock IE00BKTWZ451 |
39.63 USD |
1,695 Sold |
67,173 USD |
21/06/2024 | 21/06/2024 |
| Apellis Pharmaceuticals, Inc. Common Stock IE00BKTWZ451 |
39.22 USD |
35,305 Sold |
1,384,662 USD |
21/06/2024 | 21/06/2024 |
| Apellis Pharmaceuticals, Inc. Common Stock IE00BKTWZ451 |
57.18 USD |
18,681 Sold |
1,068,161 USD |
19/03/2024 | 19/03/2024 |
| Apellis Pharmaceuticals, Inc. Common Stock IE00BKTWZ451 |
61.14 USD |
24,000 Sold |
1,467,240 USD |
01/12/2023 | 01/12/2023 |
| Apellis Pharmaceuticals, Inc. Common Stock IE00BKTWZ451 |
61.14 USD |
24,000 Sold |
1,467,240 USD |
01/12/2023 | 01/12/2023 |
| Apellis Pharmaceuticals, Inc. Common Stock IE00BKTWZ451 |
49.00 USD |
24,000 Sold |
1,176,000 USD |
17/11/2023 | 17/10/2023 |